Yüklüyor......
DDRI-9: a novel DNA damage response inhibitor that blocks mitotic progression
The DNA damage response (DDR) is an emerging target for cancer therapy. By modulating the DDR, including DNA repair and cell cycle arrest, the efficacy of anticancer drugs can be enhanced and side effects reduced. We previously screened a chemical library and identified novel DDR inhibitors includin...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4951243/ https://ncbi.nlm.nih.gov/pubmed/26848527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7135 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|